deltatrials
Terminated PHASE2 INTERVENTIONAL 2-arm NCT01279187

The Impact of Parathyroid Hormone (PTH) on Craniofacial Osseous Regeneration in Bone

Sponsor: Eli Lilly and Company

Conditions Implant
Interventions Placebo Teriparatide
Updated 9 times since 2017 Last updated: Jan 31, 2018 Started: Feb 28, 2011 Primary completion: Mar 31, 2015 Completion: Nov 30, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study was terminated due to patient complications unrelated to study drugs

Other terminated trials from Eli Lilly and Company

See all terminations from Eli Lilly and Company

Other Implant trials with similar outcome

Browse all Implant trials

Listed as NCT01279187, this PHASE2 trial focuses on Implant and remains terminated or withdrawn. Sponsored by Eli Lilly and Company, it has been updated 9 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Mar 2018 · 13 months · monthly snapshotTerminated~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotTerminated~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotTerminated~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Terminated PHASE2

  5. Jan 2021 — Dec 2022 [monthly]

    Terminated PHASE2

▶ Show 4 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE2

  2. Mar 2018 — Jun 2018 [monthly]

    Terminated PHASE2

  3. Feb 2017 — Mar 2018 [monthly]

    Terminated PHASE2

  4. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE2

    First recorded

Feb 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Eli Lilly and Company
  • University of Michigan
Data source: University of Michigan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations